Bil Schmidtknecht blames pharmacy benefit managers for the death of his son. He won’t rest until he holds them accountable.

The launch has been delayed as officials are yet to complete scrutiny of applications and also due to issues in procurement of generic medicines, sources said.

Medicare beneficiaries who take a lot of pricey medications will get a big break come 2025. That’s when the $2,000 annual cap on out-of-pocket costs for drugs bought at the pharmacy or through ...

Mark Cuban’s Cost Plus Drugs marketplace company is designed to help hospitals and health systems source generic drugs from manufacturers.

What is a pharmacy benefit manager, anyway? Pharmacy benefit managers, or PBMs, negotiate drug prices for insurers. But sometimes PBM parent companies also own the pharmacy they’re negotiating with.

Penn Medicine partners with Mark Cuban’s pharmacy company to source generic medications for retail locations Mark Cuban’s Cost Plus Drugs marketplace company is designed to help hospitals and health ...

Penn Medicine is partnering with billionaire investor Mark Cuban to streamline the availability of generic prescription drugs for its network of pharmacy locations.

The FDA's Orange Book catalog of non-biologic drugs has been the subject of recent FTC scrutiny. What is the FTC is challenging in the Orange Book, and what impact might this have on U.S. innovation ...

Local to global: 14 nations keen to adopt India’s generic pharmacy model This development underscores India's commitment to supporting the Global South with affordable healthcare solutions and ...